RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 23-33
  • Nicox gets boost from strong prospects for glaucoma drug

    PARIS (Reuters) - French pharmaceutical firm Nicox unveiled positive Phase III results for its glaucoma drug on Thursday and said, if approved by regulators, the product could reach peak annual sales of over $1 billion worldwide. Shares in the company...
  • AstraZeneca, Shire dive as U.S. tax move punctures deal hopes

    LONDON (Reuters) - Shares in drugmakers AstraZeneca and Shire fell sharply on Tuesday after the U.S. Treasury took steps to curb "inversion" deals that allow companies to escape high U.S. taxes by reincorporating abroad. The move could jeopardize an...
  • Baltimore joins nation in offering prescription drug take-back event

    Continuing Maryland's push to stem drug abuse, officials sought Wednesday to refocus the annual prescription "take-back" day on treatment and prevention and away from law enforcement. The nationwide take-back day — which is Saturday — has...
  • AstraZeneca gets up to $500 million from Lilly for Alzheimer's drug

    LONDON (Reuters) - AstraZeneca has signed a partnership deal with U.S. rival Eli Lilly that could earn the British company up to $500 million if a promising – but risky – experimental Alzheimer's drug proves successful. AstraZeneca said in...
  • Special Report: Poultry firms systematically feed low-dose antibiotics to flocks

    ATLANTA/CHICAGO (Reuters) - Major U.S. poultry firms are administering antibiotics to their flocks far more pervasively than regulators realize, posing a potential risk to human health. Internal records examined by Reuters reveal that some of the nation'...
  • Epirus, Ranbaxy win India approval for arthritis drug copy

    (Reuters) - Epirus Biopharmaceuticals Inc said India's drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the country early next year. The company's Indian partner, Ranbaxy Laboratories Ltd, will...
  • Gilead signs hepatitis C pact to cut drug cost for poor

    NEW DELHI/MUMBAI (Reuters) - U.S. drugmaker Gilead Sciences Inc GILD.O has licensed its hepatitis C drug Sovaldi to seven India-based drugmakers that will sell far cheaper versions of the $1,000-a-pill medicine in 91 developing nations. Approximately 150...
  • Avanir's drug reduces Alzheimer's related agitation in trial

    (Reuters) - Avanir Pharmaceuticals Inc said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo, sending the company's shares up 55 percent to an over eight-year high. The company said based on the mid-...
  • China hands drugmaker GSK record $489 million fine for paying bribes

    SHANGHAI/LONDON (Reuters) - China fined GlaxoSmithKline Plc a record 3 billion yuan ($489 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the...
  • Exclusive: Akorn eyes $2 billion UCB unit in potential tax inversion - sources

    NEW YORK (Reuters) - U.S. specialty drugmaker Akorn Inc is exploring a bid for Belgian drugmaker UCB SA's U.S. subsidiary, a deal that would allow the company to move its tax domicile overseas in a practice known as inversion, according to people familiar...
  • Long-awaited diet pill gets U.S. approval

    Long-awaited diet pill gets U.S. approval
    (Reuters) - A new diet pill Contrave got approval to be sold in the United States on Wednesday, only the third obesity treatment in more than a decade to win approval from the Food and Drug Administration. Made by Orexigen Therapeutics Inc, Contrave is a...